Cargando…

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of this study was to explore the effect of bromocriptine on the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yiqun, Ponandai-srinivasan, Sakthivignesh, Frisendahl, Caroline, Andersson, Johanna K., Pavone, Dora, Stewart, Elizabeth A., Lalitkumar, Parameswaran Grace Luther, Korsching, Eberhard, Bogavarappu, Nageswara Rao, Gemzell-Danielsson, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034369/ https://www.ncbi.nlm.nih.gov/pubmed/36967761 http://dx.doi.org/10.3389/fendo.2023.1026168

Ejemplares similares

Compartmentalized gene expression profiling of receptive endometrium reveals progesterone regulated ENPP3 is differentially expressed and secreted in glycosylated form
por: Boggavarapu, Nageswara Rao, et al.
Publicado: (2016)

Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure
por: von Grothusen, Carolina, et al.
Publicado: (2022)

Stromal Heterogeneity in the Human Proliferative Endometrium—A Single-Cell RNA Sequencing Study
por: Queckbörner, Suzanna, et al.
Publicado: (2021)

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
por: Bartlett, Thomas E., et al.
Publicado: (2022)

Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
por: Bartlett, Thomas E., et al.
Publicado: (2022)

Human endometrial cell-type-specific RNA sequencing provides new insights into the embryo–endometrium interplay
por: Koel, Mariann, et al.
Publicado: (2022)

GSTM1 Gene Expression Correlates to Leiomyoma Volume Regression in Response to Mifepristone Treatment
por: Engman, Mikael, et al.
Publicado: (2013)

Transcriptomics of receptive endometrium in women with sonographic features of adenomyosis
por: Prašnikar, Erika, et al.
Publicado: (2022)

Inter-Rater Agreement for Diagnosing Adenomyosis Using Magnetic Resonance Imaging and Transvaginal Ultrasonography
por: Andersson, Johanna K., et al.
Publicado: (2023)

Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis
por: Shen, Xue, et al.
Publicado: (2019)

Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis
por: Liu, Zhiyong, et al.
Publicado: (2021)

Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis
por: Ormenezi, I., et al.
Publicado: (2022)

Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology
por: Xiang, Yuqian, et al.
Publicado: (2019)

Detection of nerve fibers in the eutopic endometrium of women with endometriosis, uterine fibroids and adenomyosis
por: Yadav, Garima, et al.
Publicado: (2021)

Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment
por: Tian, Jiao, et al.
Publicado: (2022)

The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis
por: Maia, Hugo, et al.
Publicado: (2013)

The Expression of Toll-like receptors in eutopic and ectopic endometrium and its implication in the inflammatory pathogenesis of adenomyosis
por: Jiang, Caixia, et al.
Publicado: (2017)

m(6)A RNA Methylation Regulators Contribute to Eutopic Endometrium and Myometrium Dysfunction in Adenomyosis
por: Zhai, Junyu, et al.
Publicado: (2020)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Prediction of response to bromocriptine in acromegaly.
por: Atkinson, A. B., et al.
Publicado: (1978)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis
por: Jiang, Caixia, et al.
Publicado: (2018)

RNA-seq reveals co-dysregulated circular RNAs in the adenomyosis eutopic endometrium and endometrial–myometrial interface
por: Guo, Zhengchen, et al.
Publicado: (2022)

Experiences, Feelings and Thoughts of Women Undergoing Second Trimester Medical Termination of Pregnancy
por: Andersson, Inga-Maj, et al.
Publicado: (2014)

Analysis of Reciprocally Dysregulated miRNAs in Eutopic Endometrium Is a Promising Approach for Low Invasive Diagnostics of Adenomyosis
por: Borisov, Evgeny, et al.
Publicado: (2020)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
por: Lalitkumar, Parameswaran Grace Luther, et al.
Publicado: (2023)

Management of pituitary tumour apoplexy with bromocriptine in pregnancy
por: Janssen, Nina M, et al.
Publicado: (2012)

Bromocriptine Does Not Alter Speed–Accuracy Tradeoff
por: Winkel, Jasper, et al.
Publicado: (2012)

Bromocriptine and insulin sensitivity in lean and obese subjects
por: Bahler, L, et al.
Publicado: (2016)

Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
por: Simon, Rebecca, et al.
Publicado: (2018)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
por: Harada, Tasuku, et al.
Publicado: (2023)

Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l7fmqhbbk29bk9onmutvjjp41v